Avenzoar Pharmaceuticals
PrivateLast Round
Seed
Oct 31, 2019
Total Funding Raised
$3.64M
Company Overview
Avenzoar Pharmaceuticals operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Seed round in October 2019.
Avenzoar Pharmaceuticals is a biotechnology company that develops small molecule therapeutics targeting cancer metastasis and drug resistance mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avenzoar Pharmaceuticals Comparables
Compare Avenzoar Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agastiya Biotech | 82% | |
| Persevere Therapeutics | 81% | |
| Pacylex Pharmaceuticals | 71% |
For institutional investors. Book with your work email.
Avenzoar Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 31, 2019 | ||||
| Grant | Sep 20, 2019 |
For institutional investors. Book with your work email.
Avenzoar Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2019
$525K raised in seed funding.
- Sep 20, 2019
$212K grant received from the National Cancer Institute.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 24, 2026
Avenzoar Pharma is developing highly selective drug candidates for cancer indications, with lead candidates in preclinical evaluation as it advances toward first-in-human clinical evaluation.
For institutional investors. Book with your work email.
Avenzoar Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avenzoar Pharmaceuticals's valuation, stock price, and market status.
Is Avenzoar Pharmaceuticals a public or private company?
Avenzoar Pharmaceuticals is a private company.
What is the current stock price of Avenzoar Pharmaceuticals?
Avenzoar Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Avenzoar Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avenzoar Pharmaceuticals worth (valuation)?
Valuation information for Avenzoar Pharmaceuticals is not publicly available.
Can I buy Avenzoar Pharmaceuticals stock?
Avenzoar Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avenzoar Pharmaceuticals's last funding round?
Avenzoar Pharmaceuticals's most recent funding round was Seed on October 31, 2019.
Who are the main investors in Avenzoar Pharmaceuticals?
Key investors in Avenzoar Pharmaceuticals include National Cancer Institute.
Will Avenzoar Pharmaceuticals IPO soon?
No public IPO plans have been announced for Avenzoar Pharmaceuticals.
How can I track Avenzoar Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Avenzoar Pharmaceuticals's shares on secondary markets.